Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
Eltrombopag is a compound that may help stimulate the production of platelets. This drug has
been used in treatment of low platelet counts caused by a disorder called idiopathic
thrombocytopenic purpura and information from those other research studies suggests that
Eltrombopag may help to maintain platelet counts in patients with relapsed multiple myeloma
in this research study.
In this research study,the investigators are trying to determine if Eltrombopag is effective
in maintaining platelet counts in patients who are being treated for relapsed multiple
myeloma.